While leading medical device companies, notably Johnson & Johnson, scored revenue gains in 2023, for in vitro diagnostics manufacturers it was largely a different story.
The COVID-19 bubble for medtech businesses has been deflating for some time, most visibly in terms of rapid diagnostic test...